Idiopathic Pulmonary Fibrosis: Breakthroughs and Research Evolution

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

In this video shared by RBandH (Royal Brompton & Harefield NHS Foundation Trust, a leading specialist heart and lung centre based in London and Middlesex), you can learn how the Royal Brompton’s “interstitial lung disease unit played a central part in the reclassification of IPF and related idiopathic interstitial pneumonias”. Also in this video the use of new drugs as treatments for pulmonary fibrosis is discussed, as well as how the research has been evolving and the importance of clinical trials.

Learn more about pulmonary fibrosis:

Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.